Throughout the month of September we've seen several series of
group buys coming from Canadian companies. The following three
companies reported the largest Canadian insider buys occurring in
September thus far. These companies also have a fairly consistent
history of insiders buying their company's stock.
Amica Mature Lifestyles (
Over the past week there were three insiders making notable buys
into Amica Mature Lifestyles.
Director Charles van der Lee bought a total of 683 shares at $8.95
per share. This transaction cost him a total of $6,112.85. Since
his buy the price per share has increased about 0.45%. van der Lee
now holds on to at least 58,921 shares of company stock.
James MacCallum added 10,000 shares to his stake over the past
week. The corporate executive purchased these shares at an average
price of $8.93 per share for a total transaction amount of $89,300.
Since his buy, the price per share has increased about 0.67%.
Colin Halliwell made the largest transaction, adding 50,000 shares
to his stake. Halliwell bought these shares at an average price of
$8.93 per share. This cost Halliwell a total of $446,500. Since
this buy the price per share has increased 0.67%. Halliwell holds
on to at least 285,750 shares.
The company has seen an increase in insider buying as the price
sits around a high.
The company is engaged in the design, development, marketing,
management and ownership of luxury seniors' residences. The Company
earns revenues from the ownership and operation of senior
residences, management fees, design and marketing fees during the
development, construction and lease-up of the seniors' residences.
Amica Mature Lifestyles' historical revenue and net income:
Amica Mature Lifestyles has a market cap of $275.906 million. Its
shares are currently trading at around $8.97 with a P/S ratio of
2.80, a P/E ratio of 4.80 and a P/B ratio of 1.75. The company
currently holds a dividend yield of 4.68%
Canadian Tire Corp. (
Over the past week Dean Charles McCann made several transactions
adding 5,200 shares to his stake. He bought these shares in the
price range of $91.52 to $92.10 per share. Since his purchases, the
price per share has increased approximately 0.52%.
The company has seen an increase in insider buying coming from
McCann as the price has hit a 5-year high.
Canadian Tire is comprised of two main business operations that
offer a range of retail goods and services including general
merchandise, clothing, sporting goods, petroleum and financial
services. The Company's two segments are Retail and Financial
Canadian Tire's historical revenue and net income:
The analysis on the company reports that the company's revenue has
slowed over the past year, that its price is nearing a 5-year high,
its dividend yield is near a 5-year low and its asset growth is
currently faster than its revenue.
The company has reported several big things happening over the past
week. First off the Canadian Tire REIT filed its preliminary
prospectus for initial public offering of trust units. And it was
also announced that the Maple Leaf Sports & Entertainment would
enter in to a long-term partnership with the Canadian Tire Family
of Companies. You can read more about this here.
The Peter Lynch Chart suggests that the company is currently
Canadian Tire has a market cap of $7.14 billion. Its shares are
currently trading at around $92.66 with a P/E ratio of 14.47, a P/S
ratio of 0.66 and a P/B ratio of 1.76. The company had an annual
average earnings growth of 5% over the past ten years.
GuruFocus rated Canadian Tire the business predictability rank of
Valeant Pharmaceuticals (
Over the past week corporate executive Laizer Kornwasser made a
notable buy of his company's stock. The Chairman and Executive VP
added 1,000 shares to his stake at an average price of $99.0182 per
share. This cost the insider a total of $99,018.20. Since his buy
the price per share has increased 10%. Kornwasser now holds on to a
total of 6,500 shares of company stock.
Also at the end of August Norma Provencio made a notable buy of
4,500 shares. She bought these shares at an average price of
$100.711. She now holds on to 114,468 shares of company stock.
Valeant Pharmaceuticals is a multinational specialty pharmaceutical
company that develops, manufactures and markets a broad range of
pharmaceutical products primarily in the areas of neurology,
dermatology and branded generics.
Valeant Pharmaceuticals' historical revenue and net income:
The company recently announced that it has continued via the
federal jurisdiction of Canada to the Province of British Columbia
since the resolution was passed by shareholders of the company's
annual meeting held at the end of May.
The analysis on Valeant reports that the company's price is nearing
a 10-year high, the company has issued $6.4 billion of debt over
the past three years and its P/E and P/S ratio are trading at
Valeant Pharmaceuticals International has a market cap of $36.26
billion. Its shares are currently trading at around $108.92 with a
P/E ratio of 714.29, a P/S ratio of 8.08 and a P/B ratio of 5.81.
The company had an annual average earnings growth of 4.2% over the
past ten years.
Check out the Canadian Insider Trading page for more Canadian
insider buys and sells.
If you don't have the GuruFocus Global Membership, try a
free 7-day trial here.
About GuruFocus: GuruFocus.com tracks the stocks picks and
portfolio holdings of the world's best investors. This value
investing site offers stock screeners and valuation tools. And
publishes daily articles tracking the latest moves of the world's
best investors. GuruFocus also provides promising stock ideas in 3
monthly newsletters sent to